Prep both versions to give yourself options throughout the week
Three FDA-approved GLP-1 medications are eligible under the bridge program when used to reduce excess body weight and maintain weight reduction: Wegovy (semaglutide), available as a weekly injection or daily oral tablet, manufactured by Novo Nordisk Zepbound (tirzepatide), available in the KwikPen autoinjector format, manufactured by Eli Lilly Foundayo (orforglipron), the first non-peptide, small-molecule oral GLP-1 for weight loss, recently FDA-approved and manufactured by Eli Lilly Each of these medications works by mimicking the activity of glucagon-like peptide-1, a hormone that regulates appetite, fullness, and blood sugar
These OTC heartburn medications are meant for short-term use and shouldnt be taken long-term without medical guidance
Our most requested IV formula for energy and immunity
On a broader societal level, the use of GLP-1 medications for weight loss may be reinforcing the negative stigmas around fatness and being overweight that often contribute to the development of eating disorders
